Cargando…
Using machine learning to uncover heterogeneity of beta blocker response in heart failure
A recent study by Karwath et al.(1) in The Lancet applied machine learning-based cluster analysis to pooled data from nine double-blind, randomized controlled trials of beta blockers, identifying subgroups of efficacy in patients with sinus rhythm and atrial fibrillation.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784765/ https://www.ncbi.nlm.nih.gov/pubmed/35106513 http://dx.doi.org/10.1016/j.xcrm.2021.100504 |